Each year, the National Drug and Alcohol Research Center at UNSW Sydney surveys hundreds of people who regularly use drugs in ...

A team from the Wistar Institute has demonstrated the role of Parkin—a protein implicated in Parkinson's disease—in the ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

The study said that identifiable local field potential signals, strong enough to be used for triggering therapy, were found ...

But some 80 percent of people with Parkinson's disease have GI problems, such as acid reflux, irritable bowel syndrome, and constipation, which often emerge decades before motor difficulties do. This ...

THURSDAY, Sept. 11, 2024 (HealthDay News) -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab ...

Researchers at Karolinska Institutet have identified a mechanism responsible for a serious psychiatric complication caused by ...

BOSTON - A new study finds Parkinson's disease may begin in the gut. Scientists have been interested in this possible link for some time.

Sun Pharma and Israel-based Moebius Medical on Friday said that USFDA has granted fast track designation to novel non-opioid therapy MM-II against osteoarthritis knee pain. USFDA fast track ...

People with a history of upper gastrointestinal (GI) damage have a 76% higher risk of developing Parkinson’s disease.

A man who has been living with Parkinson's disease for 20 years has described a new drug treatment as "life-altering". Rick Telford, 70, from Heaton in Newcastle, previously had to take about 20 ...

The drug candidate is intended to treat people with Parkinson's who develop levodopa induced ... proof-of-concept with potential for a better anti-dyskinetic effect compared with current treatment ...